Lyme disease followed by human granulocytic anaplasmosis in a kidney transplant recipient.
We report the case of a kidney transplant recipient who developed Lyme disease, followed by human granulocytic anaplasmosis (HGA) 3 years later. A review of all previously published cases of Lyme disease (3 cases), HGA (5 cases), and human monocytic ehrlichiosis (HME) (5 cases) in transplant recipients is presented. Manifestations of the cases reviewed were similar to those of non-transplant patients. There appeared to be no obvious correlation between immunosuppression and the occurrence of the illness in the transplant recipients. Serologic testing failed to make a diagnosis in 1 patient with HME in the literature and in our patient with HGA, but molecular tests established the diagnosis in both cases. Tandem infection was observed in 1 patient with two episodes of HME 2 years apart. A high index of suspicion for tick-borne illnesses and appropriate prevention measures are needed for transplant patients with epidemiologic risk factors.
Assi
M A
MA
Division of Infectious Diseases, Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, MN 55905-0002, USA.
Yao
J D C
JD
Walker
R C
RC
D000368:Aged; D041081:Anaplasma phagocytophilum; D000712:Anaplasmosis / Q000209:etiology*; D025065:Borrelia burgdorferi; D006084:Graft Rejection / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D016030:Kidney Transplantation; D008193:Lyme Disease / Q000209:etiology*; D008297:Male; D012196:Review Literature as Topic; D012307:Risk Factors
D007166:Immunosuppressive Agents